Deregulated Cdk5 activity is involved in inducing Alzheimer's disease

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1× · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Amyloid Precursor Protein Processing and Alzheimer's Disease

O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · see citing works

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014 · see citing works

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · see citing works

Translating cell biology into therapeutic advances in Alzheimer's disease

Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,588 · see citing works

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541 · see citing works

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · see citing works

Neurotoxicity induces cleavage of p35 to p25 by calpain

Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,057 · see citing works

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70198-8 · Cited by 1,054 · see citing works

A decade of CDK5

Dhavan, R., & Tsai, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096019 · Cited by 1,052 · see citing works

Tau pathology in Alzheimer disease and other tauopathies

Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · see citing works

A family of human cdc2‐related protein kinases.

Meyerson, M. M., Enders, G. H., Wu, C. L., Su, L., Gorka, C., Nelson, C. E., Harlow, E., & Tsai, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 925 · see citing works

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

Tsai, L., Delalle, I., Caviness, V. S., Chae, T. H., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 923 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease

Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · see citing works

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., & Kulkarni, A. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11173 · Cited by 897 · see citing works

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 816 · see citing works

A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease

Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740 · see citing works

Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729 · see citing works

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68

Chen, H., Lanzetta, K. M., Pascarelle, S. M., & Yahata, N. (2000) · RePEc: Research Papers in Economics · Cited by 680 · see citing works

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

Cruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609 · see citing works

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.Preprint

Nikolić, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., & Tsai, L. (1996) · Genes & Development · doi:10.1101/gad.10.7.816 · Cited by 599 · see citing works

Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease

Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · see citing works

Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

Selkoe, D. J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3111 · Cited by 538 · see citing works

Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo

Noble, W. J., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J. L., Gaynor, K., LaFrancois, J. J., Wang, L., Kondo, T., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00259-9 · Cited by 511 · see citing works

Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 490 · see citing works

The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.

Shen, J., & Kelleher, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608332104 · Cited by 485 · see citing works

Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease

Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483 · see citing works

APP processing is regulated by cytoplasmic phosphorylation

Lee, M.-S., Kao, S.-C., Lemere, C. A., Xia, W., Tseng, H.-C., Zhou, Y., Neve, R. L., Ahlijanian, M. K., & Tsai, L. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200301115 · Cited by 457 · see citing works

Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway

Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455 · see citing works

Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68

Chen, H., Lanzetta, K. M., Pascarelle, S., & Yahata, N. (2000) · Nature · doi:10.1038/35046031 · Cited by 447 · see citing works

Tau phosphorylation: physiological and pathological consequences

Stoothoff, W. H., & Johnson, G. V. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 439 · see citing works

p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during Neurodevelopment

Ko, J. P., Humbert, S., Bronson, R. T., Takahashi, S., Kulkarni, A. B., Li, E., & Tsai, L. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06758.2001 · Cited by 385 · see citing works

New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 378 · see citing works

Leisure activities and the risk of amnestic mild cognitive impairment in the elderly

Verghese, J., LeValley, A., Derby, C., Kuslansky, G., Katz, M., Hall, C., Buschke, H., & Lipton, R. B. (2006) · Neurology · doi:10.1212/01.wnl.0000202520.68987.48 · Cited by 373 · see citing works

Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy

Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen�, M., Gažová, Z., Mandelkow�, E., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507753200 · Cited by 350 · see citing works

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

Ahlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A. B., Kowsz, K. P., McCarthy, S. A., Coskran, T., Carlo, A. A., Seymour, P. A., Burkhardt, J. E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040577797 · Cited by 339 · see citing works

Deregulation of Cdk5 in a Mouse Model of ALS

Nguyen, M. D., Larivière, R., & Julien, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 339 · see citing works

Aberrant neurofilament phosphorylation in Alzheimer disease.

Sternberger, N. H., Sternberger, L. A., & ULRICH, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4274 · Cited by 338 · see citing works

p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway

Patrick, G. N., Zhou, P., Kwon, Y. T., Howley, P. M., & Tsai, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24057 · Cited by 311 · see citing works

Cdk5 is essential for synaptic vesicle endocytosis

Tan, T. C., Valova, V. A., Malladi, C. S., Graham, M. E., Berven, L. A., Jupp, O. J., Hansra, G., McClure, S. J., Šarčević, B., Boadle, R. A., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb1020 · Cited by 299 · see citing works

Oxidative Stress in Neurodegeneration

Shukla, V., Mishra, S. K., & Pant, H. C. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/572634 · Cited by 292 · see citing works

Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles

Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608485200 · Cited by 282 · see citing works

Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression.

Hellmich, M. R., Pant, H. C., Wada, E., & Battey, J. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10867 · Cited by 278 · see citing works

Phosphorylation-dependent Regulation of the Interaction of Amyloid Precursor Protein with Fe65 Affects the Production of β-Amyloid

Ando, K., Iijima, K., Elliott, J. I., Kirino, Y., & Suzuki, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104059200 · Cited by 261 · see citing works

Cdk5 deregulation in the pathogenesis of Alzheimer's disease

Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258 · see citing works

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II

Yamaguchi, H., Ishiguro, K., Uchida, T., Takashima, A., Lemere, C. A., & Imahori, K. (1996) · Acta Neuropathologica · doi:10.1007/s004010050513 · Cited by 253 · see citing works

Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease

Yuede, C. M., Zimmerman, S., Dong, H., Kling, M. J., Bero, A. W., Holtzman, D. M., Timson, B. F., & Csernansky, J. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.002 · Cited by 250 · see citing works

Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5

Iijima, K., Ando, K., Takeda, S., Satoh, Y., Seki, T., Itohara, S., Greengard, P., Kirino, Y., Nairn, A. C., & Suzuki, T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751085.x · Cited by 234 · see citing works

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration

Pei, J.-J., Grundke-Iqbal, I., Iqbal, K., Bogdanovic, N., Winblad, B., & Cowburn, R. F. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00296-0 · Cited by 226 · see citing works

cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization.

Shetty, K. T., Link, W. T., & Pant, H. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6844 · Cited by 206 · see citing works

Alzheimer Disease

Smith, M. A. (1998) · International review of neurobiology · doi:10.1016/s0074-7742(08)60607-8 · Cited by 201 · see citing works

Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.

Nukina, N., Kosik, K. S., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3415 · Cited by 198 · see citing works

A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons

Zheng, Y., Kesavapany, S., Gravell, M., Hamilton, R. S., Schubert, M., Amin, N. D., Albers, W., Grant, P. G., & Pant, H. C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600441 · Cited by 190 · see citing works

p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton

Humbert, S., Dhavan, R., & Tsai, L. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.6.975 · Cited by 188 · see citing works

Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice

Piedrahita, D., Hernández, I., Tobon, A., Fedorov, D., Obara, B., Manjunath, B. S., Boudreau, R. L., Davidson, B. L., LaFerla, F. M., Gallego-Gómez, J. C., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3637-10.2010 · Cited by 184 · see citing works

Current approaches in the treatment of Alzheimer's disease

Shah, R. S., Lee, H., Zhu, X., Perry, G. L., Smith, M. A., & Castellani, R. J. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.02.005 · Cited by 176 · see citing works

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain

Lee, K., Clark, A. W., Rosales, J. L., Chapman, K. R., Fung, T. S., & Johnston, R. N. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00026-7 · Cited by 168 · see citing works

Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

Pei, J.-J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., & Cowburn, R. F. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3107 · Cited by 165 · see citing works

Phosphorylated Neurofilament Antigens in Neurofibrillary Tangles in Alzheimerʼs Disease

Cork, L. C., Sternberger, N. H., Sternberger, L. A., Casanova, M. F., Struble, R. G., & Price, D. L. (1986) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198601000-00005 · Cited by 158 · see citing works

Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

Cras, P. P., Smith, M. A., Richey, P. L., Siedlak, S. L., Mulvihill, P., & Perry, G. L. (1995) · Acta Neuropathologica · doi:10.1007/bf00309621 · Cited by 156 · see citing works

Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

Zhu, X.-W., Rottkamp, C., Hartzler, A., Sun, Z., Takeda, A., Boux, H., Shimohama, S., Perry, G., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00597.x · Cited by 151 · see citing works

Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation

Iqbal, K., Zaidi, T., Bancher, C., & Grundke, I. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00650-4 · Cited by 150 · see citing works

Truncation of CDK5 Activator p35 Induces Intensive Phosphorylation of Ser202/Thr205 of Human Tau

Hashiguchi, M., Saito, T., Hisanaga, S., & Hashiguchi, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207426200 · Cited by 149 · see citing works

Intracellular Targets of Paullones

Knockaert, M., Wieking, K., Schmitt, S., Leost, M., Grant, K. M., Mottram, J. C., Kunick, C., & Meijer, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202651200 · Cited by 144 · see citing works

Cyclin-Dependent Kinase 5 Is Required for Associative Learning

Fischer, A., Sananbenesi, F., Schrick, C., Spiess, J., & Radulović, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03700.2002 · Cited by 137 · see citing works

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

Maier, M., Seabrook, T. J., Lazo, N. D., Jiang, L., Das, P., Janus, C., & Lemere, C. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0381-06.2006 · Cited by 134 · see citing works

Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction

Sun, K., de Pablo, Y., Vincent, F., & Shah, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05616.x · Cited by 123 · see citing works

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs

Rudrabhatla, P., Jaffe, H., & Pant, H. C. (2011) · The FASEB Journal · doi:10.1096/fj.11-181297 · Cited by 121 · see citing works

Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation

Avraham, E., Rott, R., Liani, E., Szargel, R., & Engelender, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608243200 · Cited by 121 · see citing works

Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain: A Clinicopathologic Study

Steinerman, J. R., Irizarry, M., Scarmeas, N., Raju, S., Brandt, J., Albert, M., Blacker, D., Hyman, B., & Stern, Y. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.906 · Cited by 104 · see citing works

Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease

Helal, C. J., Sanner, M. A., Cooper, C. B., Gant, T. G., Adam, M. D., Lucas, J. C., Kang, Z., Kupchinsky, S., Ahlijanian, M. K., Tate, B. F., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.006 · Cited by 103 · see citing works

A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation

Zheng, Y., Amin, N. D., Hu, Y., Rudrabhatla, P., Shukla, V., Kanungo, J., Kesavapany, S., Grant, P. G., Albers, W., & Pant, H. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134643 · Cited by 91 · see citing works

Cyclin-dependent Kinase 5 (Cdk5) Activation Domain of Neuronal Cdk5 Activator

Tang, D., Chun, A. C. S., Zhang, M., & Wang, J. H.-C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12318 · Cited by 91 · see citing works

A peptide derived from cyclin‐dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells

Zheng, Y., Li, B., Amin, N. D., Albers, W., & Pant, H. C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03133.x · Cited by 86 · see citing works

Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites

Ishiguro, K., Sato, K., Takamatsu, M., Park, J., Uchida, T., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12206-0 · Cited by 84 · see citing works

Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class.

Yen, S.-H. C., Gaskin, F., & Fu, S. M. (1983) · PubMed · Cited by 84 · see citing works

Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments.

Liu, W.-K., Williams, R. T., Hall, F. L., Dickson, D. W., & Yen, S.-H. C. (1995) · PubMed Central · Cited by 78 · see citing works

Cyclin‐dependent kinase 5 (cdk5) activation requires interaction with three domains of p35

Amin, N. D., Albers, W., & Pant, H. C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10116 · Cited by 77 · see citing works

Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death

Chang, K., Multani, P. S., Sun, K.-H., Vincent, F., de Pablo, Y., Ghosh, S., Gupta, R., Lee, H.-P., Lee, H., Smith, M. A., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-07-0654 · Cited by 76 · see citing works

Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry

Lund, E. T., McKenna, R., EVANS, D. B., Sharma, S. K., & Mathews, W. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00130.x · Cited by 74 · see citing works

Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease

Chang, K., de Pablo, Y., Lee, H., Lee, H., Smith, M. A., & Shah, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06687.x · Cited by 74 · see citing works

Colocalization and Fluorescence Resonance Energy Transfer between cdk5 and AT8 Suggests a Close Association in Pre-Neurofibrillary Tangles and Neurofibrillary Tangles

Augustinack, J. C., Sanders, J. L., Tsai, L., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.6.557 · Cited by 72 · see citing works

Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF‐M/H) in Alzheimer's disease by iTRAQ

Rudrabhatla, P., Grant, P., Jaffe, H., Strong, M. J., & Pant, H. C. (2010) · The FASEB Journal · doi:10.1096/fj.10-157859 · Cited by 65 · see citing works

Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations

Maarouf, C. L., Daugs, I. D., Spina, S., Vidal, R., Kokjohn, T. A., Patton, R., Kalback, W. M., Luehrs, D. C., Walker, D. G., Castaño, E. M., et al. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-20 · Cited by 65 · see citing works

Interaction of Neuronal Cdc2-like Protein Kinase with Microtubule-associated Protein Tau

Sobue, K., Agarwal-Mawal, A., Li, W., Sun, W., Miura, Y., & Paudel, H. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000784200 · Cited by 64 · see citing works

Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

Rohn, T. T., & Head, E. (2009) · PubMed Central · Cited by 63 · see citing works

Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease

Alvira, D., Ferrer, I., Cuesta, J., García‐Castro, B., Pallàs, M., & Camins, A. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.005 · Cited by 60 · see citing works

Cyclin‐dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress

SHEA, T. B., Zheng, Y., Ortiz, D., & Pant, H. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20099 · Cited by 55 · see citing works

Identification of Caspase-6-Mediated Processing of the Valosin Containing Protein (p97) in Alzheimer's Disease: A Novel Link to Dysfunction in Ubiquitin Proteasome System-Mediated Protein Degradation

Halawani, D., Tessier, S., Anzellotti, D., Bennett, D. A. A., Latterich, M., & LeBlanc, A. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5874-09.2010 · Cited by 53 · see citing works

Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer’s disease

Helal, C. J., Kang, Z., Lucas, J. C., Gant, T. G., Ahlijanian, M. K., Schachter, J. B., Richter, K. E. G., Cook, J. M., Menniti, F. S., Kelly, K. A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.019 · Cited by 50 · see citing works

Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5

Kesavapany, S., Zheng, Y., Amin, N. D., & Pant, H. C. (2007) · Biotechnology Journal · doi:10.1002/biot.200700057 · Cited by 34 · see citing works

Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins

Zhou, J. H. S., Wang, H., Feng, Y., & Chen, J. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.009 · Cited by 27 · see citing works

Untitled work

Shinpo (2000) · doi:10.1002/1097-4547(20001101)62:3

Tau-targeting therapies for Alzheimer disease

Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113 · see citing works

Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy

Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 454 · see citing works

Physiological and pathological phosphorylation of tau by Cdk5

Kimura, T., Ishiguro, K., & Hisanaga, S. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00065 · Cited by 297 · see citing works

The Role of Cdk5 in Alzheimer’s Disease

Liu, S., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 273 · see citing works

Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment

Folch, J., Petrov, D., Ettcheto, M., Abad, S., Sánchez-López, E., García, M. L., Olloquequi, J., Beas-Zarate, C., Auladell, C., & Camins, A. (2016) · Neural Plasticity · doi:10.1155/2016/8501693 · Cited by 270 · see citing works

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works

Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration

Baudry, M., & Bi, X. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.007 · Cited by 223 · see citing works

Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease

Pedrós, I., Petrov, D., Allgaier, M., Sureda, F. X., Barroso, E., Beas‐Zárate, C., Auladell, C., Pallàs, M., Vázquez‐Carrera, M., Casadesús, G., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.025 · Cited by 203 · see citing works

Copper as a key regulator of cell signalling pathways

Grubman, A., & White, A. R. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.11 · Cited by 199 · see citing works

Three decades of Cdk5

Pao, P., & Tsai, L. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00774-y · Cited by 150 · see citing works

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease

Thapa, P., Upadhyay, S. P., Suo, W. Z., Singh, V., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104681 · Cited by 148 · see citing works

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

Marttinen, M., Kurkinen, K. M. A., Soininen, H. S., Haapasalo, A., & Hiltunen, M. O. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0013-z · Cited by 129 · see citing works

Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders

Muñoz-Lasso, D. C., Mateo, C. R., Pallardó, F. V., & González‐Cabo, P. (2020) · Cells · doi:10.3390/cells9020358 · Cited by 123 · see citing works

Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses

Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111 · see citing works

C dk5 regulates multiple cellular events in neural development, function and disease

Kawauchi, T. (2014) · Development Growth & Differentiation · doi:10.1111/dgd.12138 · Cited by 109 · see citing works

Inhibition of c‐ J un N ‐terminal kinase activation reverses A lzheimer disease phenotypes in APP swe/ PS 1dE 9 mice

Zhou, Q., Wang, M., Du, Y., Zhang, W., Bai, M., Zhang, Z., Li, Z., & Miao, J. (2015) · Annals of Neurology · doi:10.1002/ana.24361 · Cited by 105 · see citing works

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102 · see citing works

C dk5‐ D ependent A ctivation of N euronal I nflammasomes in P arkinson's D isease

Zhang, P., Shao, X., Qi, G., Chen, Q., Bu, L.-L., Chen, L., Shi, J., Ming, J., & Tian, B. (2016) · Movement Disorders · doi:10.1002/mds.26488 · Cited by 102 · see citing works

Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain

Shah, K., & Rossie, S. S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0525-3 · Cited by 102 · see citing works

Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice

Rao, M. V., McBrayer, M. K., Campbell, J., Kumar, A., Hashim, A. T., Sershen, H. W., Stavrides, P. H., Ohno, M., Hutton, M., & Nixon, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1132-14.2014 · Cited by 99 · see citing works

S -nitrosation of proteins relevant to Alzheimer’s disease during early stages of neurodegeneration

Seneviratne, U. I., Nott, A., Bhat, V. B., Ravindra, K. C., Wishnok, J. S., Tsai, L., & Tannenbaum, S. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521318113 · Cited by 97 · see citing works

The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis

Moncini, S., Lunghi, M., Valmadre, A., Grasso, M., Vescovo, V. D., Riva, P., Denti, M. A., & Venturin, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0002-4 · Cited by 93 · see citing works

Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing

Bouter, Y., Kacprowski, T., Weißmann, R., Dietrich, K., Borgers, H., Brauß, A., Sperling, C., Wirths, O., Albrecht, M., Jensen, L. R., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00075 · Cited by 91 · see citing works

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy

Gaur, K., Vázquez-Salgado, A. M., Duran-Camacho, G., Dominguez-Martinez, I., Benjamín-Rivera, J. A., Fernández-Vega, L., Carmona‐Sarabia, L., García, A. C., Pérez-Deliz, F., Román, J. A. M., et al. (2018) · Inorganics · doi:10.3390/inorganics6040126 · Cited by 91 · see citing works

Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery

Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88 · see citing works

Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid

Tsai, S., Pokrass, M. J., Klauer, N. R., Nohara, H., & Su, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422001112 · Cited by 77 · see citing works

Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation

Aaseth, J., Alexander, J., Bjørklund, G., Hestad, K. A., Dušek, P., Roos, P. M., & Alehagen, U. (2016) · BioMetals · doi:10.1007/s10534-016-9959-8 · Cited by 73 · see citing works

Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss

Nuschke, A. C., Farrell, S. R. M., Levesque, J. M., & Chauhan, B. C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.006 · Cited by 71 · see citing works

Linking pathways in the developing and aging brain with neurodegeneration

Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 67 · see citing works

The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease

Zubčić, K., Hof, P. R., Šimić, G., & Jembrek, M. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.572308 · Cited by 69 · see citing works

Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein

Klinman, E., & Holzbaur, E. L. F. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.032 · Cited by 66 · see citing works

A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5

Shah, K., & Lahiri, D. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9792-7 · Cited by 67 · see citing works

Cdk5–Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models

Shi, C., Viccaro, K., Lee, H., & Shah, K. (2016) · Journal of Cell Science · doi:10.1242/jcs.185009 · Cited by 67 · see citing works

CDK5: Key Regulator of Apoptosis and Cell Survival

Roufayel, R., & Murshid, N. (2019) · Biomedicines · doi:10.3390/biomedicines7040088 · Cited by 65 · see citing works

A mechanistic survey of Alzheimer's disease

Tang, Y., Zhang, D., Gong, X., & Zheng, J. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106735 · Cited by 65 · see citing works

Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity

Wang, Y., Zhao, J., Guo, F., Gao, X., Xie, X., Liu, S., Yang, X., Xinfeng, Y., Zhang, L., Ye, Y., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00170 · Cited by 62 · see citing works

Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer’s Disease Rats Abrogating Aβ 40/42 and Tau Hyperphosphorylation

Das, T. K., Jana, P., Chakrabarti, S. K., & Hamid, M. R. W. A. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190135 · Cited by 60 · see citing works

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease

Aaseth, J., Skalny, A. V., Roos, P. M., Alexander, J., Aschner, M., & Tinkov, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179461 · Cited by 57 · see citing works

Tau acts as a mediator for<scp>A</scp>lzheimer's disease‐related synaptic deficits

Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53 · see citing works

Design, Synthesis, and Structure–Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer’s Disease

Sağlık, B. N., Osmani̇ye, D., Çevik, U. A., Levent, S., Çavuşoğlu, B. K., Özkay, Y., & Kaplancıklı, Z. A. (2020) · Molecules · doi:10.3390/molecules25184312 · Cited by 52 · see citing works

Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease

Chen, C., Jiang, X., Li, Y., Yu, H., Li, S., Zhang, Z., Xu, H., Yang, Y., Liu, G., Zhu, F., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.002 · Cited by 51 · see citing works

Parkinson mice show functional and molecular changes in the gut long before motoric disease onset

Gries, M., Christmann, A., Schulte, S., Weyland, M., Rommel, S., Martin, M., Baller, M. K., Röth, R., Schmitteckert, S., Unger, M. M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00439-2 · Cited by 53 · see citing works

A machine learning approach to unmask novel gene signatures and prediction of Alzheimer's disease within different brain regions

Sharma, A., & Dey, P. (2021) · Genomics · doi:10.1016/j.ygeno.2021.04.028 · Cited by 46 · see citing works

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

Wang, L., Shui, X., Diao, Y., Chen, D., Zhou, Y., & Lee, T. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216259 · Cited by 46 · see citing works

Proteomic Analysis of Cerebrospinal Fluid in Alzheimer's Disease: Wanted Dead or Alive

Galik-Olah, Z., Kalman, J. L., Tóth, M. E., Zvara, Á., Sántha, M., Ivitz, E., Janka, Z., & Pákáski, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140141 · Cited by 43 · see citing works

Cyclin dependent kinase 5: A novel avenue for Alzheimer’s disease

Bhounsule, A. S., Bhatt, L. K., Prabhavalkar, K. S., & Oza, M. J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.006 · Cited by 43 · see citing works

Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease

Rockenstein, E. M., Desplats, P., Ubhi, K. K., Mante, M., Florio, J. B., Adame, A., Winter, S., Brandstaetter, H., Meier, D., & Masliah, E. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.04.008 · Cited by 42 · see citing works

PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice

Toba, J., Nikkuni, M., Ishizeki, M., Yoshii, A., Watamura, N., Inoue, T., & Ohshima, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.012 · Cited by 41 · see citing works

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer¿s disease correlates with pathology

Rosenberger, A. F. N., Rozemüller, A. J. M., van der Flier, W. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0079-9 · Cited by 39 · see citing works

Golgin-84-associated Golgi fragmentation triggers tau hyperphosphorylation by activation of cyclin-dependent kinase-5 and extracellular signal-regulated kinase

Jiang, Q., Wang, L., Guan, Y., Xu, H., Niu, Y., Han, L., Wei, Y., Li, L., Chu, J., Wang, Q., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.022 · Cited by 40 · see citing works

MultiBac: Baculovirus-Mediated Multigene DNA Cargo Delivery in Insect and Mammalian Cells

Gupta, K., Toelzer, C., Sari, D., Fitzgerald, D. J., Schaffitzel, C., & Berger, I. (2019) · Viruses · doi:10.3390/v11030198 · Cited by 39 · see citing works

Rescue of impaired late–phase long-term depression in a tau transgenic mouse model

Ahmed, T., Blum, D. L., Burnouf, S., Demeyer, D., Buée‐Scherrer, V., D’Hooge, R., Buée, L., & Balschun, D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.015 · Cited by 38 · see citing works

Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease

Jürgenson, M., Zharkovskaja, T., Noortoots, A., Ma, M., Герович, Б. А., Zapolski, M., & Zharkovsky, A. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13165 · Cited by 38 · see citing works

Divergent and convergent roles for kinases and phosphatases in neurofilament dynamics

Lee, S., Pant, H. C., & SHEA, T. B. (2014) · Journal of Cell Science · doi:10.1242/jcs.153346 · Cited by 37 · see citing works

Golgi Complex Dynamics and Its Implication in Prevalent Neurological Disorders

Caracci, M. O., Fuentealba, L. M., & Marzolo, M. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00075 · Cited by 37 · see citing works

Role of Cdk5 in Amyloid-beta Pathology of Alzheimer’s Disease

Lu, T.-T., Wan, C., Yang, W., & Cai, Z. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191210094435 · Cited by 36 · see citing works

Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes

Petrov, A. M., Mast, N., Li, Y., Denker, J. A., & Pikuleva, I. A. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa043 · Cited by 34 · see citing works

Tau; One Protein, So Many Diseases

Tabeshmehr, P., & Eftekharpour, E. (2023) · Biology · doi:10.3390/biology12020244 · Cited by 33 · see citing works

Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons

Hartl, D., Klatt, S., Roch, M., Konthur, Z., Klose, J., Willnow, T. E., & Rohe, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065920 · Cited by 33 · see citing works

Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer’s Disease Pathogenesis

Nikhil, K., Viccaro, K., & Shah, K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1114-9 · Cited by 31 · see citing works

Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca 2+ -Mediated Calpain Activation

Park, J., Kim, B., Chae, U., Lee, D. G., Kam, M. K., Lee, S., Lee, S., Lee, H., Park, J., & Lee, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6810 · Cited by 29 · see citing works

Proteomics analysis of prefrontal cortex of Alzheimer’s disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology

Montero‐Calle, A., Coronel, R., Garranzo‐Asensio, M., Solís‐Fernández, G., Rábano, A., Rı́os, V. D. L., Fernández‐Aceñero, M. J., Mendes, M. L., Martínez‐Useros, J., Megı́as, D., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04791-y · Cited by 29 · see citing works

Phosphorylation in two discrete tau domains regulates a stepwise process leading to postsynaptic dysfunction

Teravskis, P. J., Oxnard, B. R., Miller, E. C., Kemper, L. J., Ashe, K. H., & Liao, D. (2019) · The Journal of Physiology · doi:10.1113/jp277459 · Cited by 29 · see citing works

Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in Alzheimer's disease model

Nikhil, K., & Shah, K. (2017) · Journal of Cell Science · doi:10.1242/jcs.205666 · Cited by 28 · see citing works

Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 32 · see citing works

Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron

Chao, A., Chen, C.-H., Wu, M.-H., Hou, B.-Y., & Yang, D. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118628 · Cited by 27 · see citing works

The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease

Culibrk, R. A., & Hahn, M. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.583884 · Cited by 27 · see citing works

Phosphoregulation of the septin cytoskeleton in neuronal development and disease

Werner, B., & Yadav, S. (2022) · Cytoskeleton · doi:10.1002/cm.21728 · Cited by 18 · see citing works

The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease

Cissé, M., Duplan, E., & Checler, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00229 · Cited by 27 · see citing works

LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains

Mórotz, G. M., Glennon, E. B. C., Gómez‐Suaga, P., Lau, D. H. W., Robinson, E., Sedlak, E., Vagnoni, A., Noble, W. J., & Miller, C. C. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0715-5 · Cited by 27 · see citing works

Protein Interaction Module–assisted Function X (PIMAX) Approach to Producing Challenging Proteins Including Hyperphosphorylated Tau and Active CDK5/p25 Kinase Complex

Sui, D., Xu, X., Ye, X., Liu, M., Mianecki, M., Rattanasinchai, C., Buehl, C. J., Deng, X., & Kuo, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o114.044412 · Cited by 26 · see citing works

Protein Profiles Associated With Context Fear Conditioning and Their Modulation by Memantine

Ahmed, M. M., Dhanasekaran, A. R., Block, A., Tong, S., Costa, A. C. S., & Gardiner, K. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035568 · Cited by 23 · see citing works

VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration

Qi, F., Zuo, Z., Hu, K., Wang, R., Wu, T., Liu, H., Tang, J., Wang, Q., Xie, Y., Tan, L., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02097-w · Cited by 23 · see citing works

CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review

Garemilla, S. S., Kumari, R., & Kumar, R. K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176760 · Cited by 22 · see citing works

Ginsenoside compound K ameliorates Alzheimer’s disease in HT22 cells by adjusting energy metabolism

Chen, X., Li, H., Yang, Q., Lan, X., Wang, J., Cao, Z., Shi, X., Li, J., Kan, M., Qu, X., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04988-0 · Cited by 22 · see citing works

Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease

Eremin, D. V., Kondaurova, E. M., Rodnyy, A. Y., Molobekova, C. A., Kudlay, D. A., & Naumenko, V. S. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923120064 · Cited by 22 · see citing works

Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration

Yeboah, F., Kim, T., Bill, A., & Dettmer, U. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104543 · Cited by 22 · see citing works

Association between lower body temperature and increased tau pathology in cognitively normal older adults

Blessing, E., Parekh, A., Betensky, R. A., Babb, J. S., Saba, N., Debure, L., Varga, A. W., Ayappa, I. A., Rapoport, D. M., Butler, T., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105748 · Cited by 22 · see citing works

Tfh Exosomes Derived from Allergic Rhinitis Promote DC Maturation Through miR-142-5p/CDK5/STAT3 Pathway

Teng, Z.-X., Zhou, X., Xu, R.-T., Zhu, F., Bing, X., Guo, N., Shi, L., Qi, W., Liu, C., & Xia, M. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s365217 · Cited by 22 · see citing works

Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse

Ontiveros‐Torres, M. Á., Labra‐Barrios, M. L., Díaz-Cintra, S. Y., Aguilar-Vázquez, A. R., Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G. L., Florán, B., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150837 · Cited by 21 · see citing works

Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice

Guerra‐Araiza, C., Neri-Gómez, T., Espinosa‐Raya, J., Díaz-Cintra, S. Y., Segura-Uribe, J. J., Orozco-Suárez, S. A., & Gallardo, J. M. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.205098 · Cited by 21 · see citing works

Wnt5a Promotes Cortical Neuron Survival by Inhibiting Cell-Cycle Activation

Zhou, L., Chen, D., Huang, X., Long, F., Cai, H., Yao, W., Chen, Z., Liao, Z.-J., Deng, Z., Tan, S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00281 · Cited by 21 · see citing works

The Potential Role of Dysregulated miRNAs in Alzheimer’s Disease Pathogenesis and Progression

Patel, A. A., Ganepola, G. A. P., Rutledge, J. R., & Chang, D. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181078 · Cited by 22 · see citing works

Hippocampal Gene Expression Meta-Analysis Identifies Aging and Age-Associated Spatial Learning Impairment (ASLI) Genes and Pathways

Uddin, R. K., & Singh, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069768 · Cited by 20 · see citing works

Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons

Marlier, Q., D’aes, T., Verteneuil, S., Vandenbosch, R., & Malgrange, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03548-1 · Cited by 20 · see citing works

Active Compounds of Panax ginseng in the Improvement of Alzheimer’s Disease and Application of Spatial Metabolomics

Zhang, M., Niu, H., Li, Q., Jiao, L., Li, H., & Wu, W. (2023) · Pharmaceuticals · doi:10.3390/ph17010038 · Cited by 20 · see citing works

Cdk5r1 Overexpression Induces Primary β -Cell Proliferation

Draney, C., Hobson, A., Grover, S. G., Jack, B. O., & Tessem, J. S. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6375804 · Cited by 20 · see citing works

Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease

Basurto‐Islas, G., Diaz, M. C., Zavala-Ocampo, L. M., Martínez‐Herrera, M., & López-Camacho, P. Y. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.202400721 · Cited by 19 · see citing works

APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice

Baltissen, D., Bold, C. S., Rehra, L., Banićević, M., Fricke, J., Just, J., Ludewig, S., Buchholz, C. J., Körte, M., & Müller, U. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1106176 · Cited by 17 · see citing works

Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP / PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR‐STEP61 signaling

He, R., Li, L., Liu, L., Ma, Y., Fan, S., Liu, L., Li, W., & Xian, X. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15874 · Cited by 17 · see citing works

Protective effect of donepezil hydrochloride on cerebral ischemia/reperfusion injury in mice

Wang, T., Lv, P., Jin, W., Zhang, H., LANG, J., & Fan, M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1823 · Cited by 16 · see citing works

CRMP2 Participates in Regulating Mitochondrial Morphology and Motility in Alzheimer’s Disease

Brustovetsky, T., Khanna, R., & Brustovetsky, N. (2023) · Cells · doi:10.3390/cells12091287 · Cited by 15 · see citing works

Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances

Cazarim, M. D. S., Moriguti, J. C., Ogunjimi, A. T., & Pereira, L. R. L. (2016) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2015.01980112 · Cited by 18 · see citing works

Friend or Foe? The Varied Faces of Homeostatic Synaptic Plasticity in Neurodegenerative Disease

Taylor, H. B. C., & Jeans, A. F. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.782768 · Cited by 15 · see citing works

Isoliensinine ameliorates cognitive dysfunction in AlCl3/D-gal-induced Alzheimer's disease-like mice by inhibiting the calcium signaling pathway.

Li, J.-Q., Ma, X.-H., Dai, H., Wang, C.-C., Zhang, J., & Meng, X.-L. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119567 · Cited by 15 · see citing works

Cdk5-Mediated Brain Unfolded Protein Response Upregulation Associated with Cognitive Impairments in Type 2 Diabetes and Ameliorative Action of NAC

Saha, D., Paul, S. C., Gaharwar, U., Priya, A., Neog, A., Singh, A., & Binukumar, B. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00341 · Cited by 13 · see citing works

Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis

Tang, D., Sun, C., Yang, J., Fan, L., & Wang, Y.-G. (2023) · Life · doi:10.3390/life13112203 · Cited by 16 · see citing works

Cyclin‐dependent kinase 5 ( CDK5 ) inhibitors in Parkinson disease

Alrouji, M., Al‐kuraishy, H. M., Al-Gareeb, A. I., Alshammari, M. S., Alexiou, A. T., Papadakis, M., Bahaa, M. M., & Batiha, G. E. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18412 · Cited by 14 · see citing works

Decoding molecular mechanisms: brain aging and Alzheimer’s disease

Hayat, M., Syed, R. A., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R. A., Albassam, L. A. M., Kaleem, I., Wang, X., Wang, R., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01403 · Cited by 14 · see citing works

Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression

Mairet‐Coello, G., & Polleux, F. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.011 · Cited by 14 · see citing works

Role of cdk5 in the Pathogenesis of Alzheimer’s Disease

Lau, L., & Ahlijanian, M. K. (2003) · Neurosignals · doi:10.1159/000074622 · Cited by 60 · see citing works

Cdk5: One of the links between senile plaques and neurofibrillary tangles?

Lee, M.-S., & Tsai, L. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5207 · Cited by 104 · see citing works

Cdk5, a therapeutic target for Alzheimer's disease?

Tsai, L., Lee, M.-S., & Cruz, J. C. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.019 · Cited by 122 · see citing works

Role of cyclin-dependent kinase 5 in neurodegenerative disorders

Varma, K. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp12.1190 · Cited by 1 · see citing works

Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease

Monaco, E. A. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480519 · Cited by 56 · see citing works